BodybyBTL - Discover how people have been transformed (2024)

June 18, 2024

BTL Industries, a global leader in medical devices for wellness, aesthetics, and longevity, is pleased to announce its strategic partnership with JANZ Corporation, a renowned medical equipment provider and supplies to U.S. Government healthcare facilities and clinics. This collaboration aims to deliver cutting-edge solutions to enhance the physical strength and well-being of U.S. military personnel and veterans.

JANZ Corporation is recognized for its extensive range of medical supplies, catering to the needs of active U.S. military bases and specialized VA facilities. Their robust contract portfolio simplifies the procurement process for government purchasing agents, ensuring timely and efficient access to necessary medical products.

Through this partnership, BTL Industries will offer its revolutionary Emsculpt Neo technology to military and veteran communities via JANZ Corporation. Emsculpt Neo, renowned for strengthening, toning, and firming the muscles and eliminating fat, will be utilized to enhance physical performance, improve body composition, and strengthen muscles, thereby reducing the risk of injury in combat and improving the quality of life. Furthermore, this innovative technology offers both proactive and corrective treatment options for those who want to build or strengthen their muscles. Based on several clinical studies, this device has demonstrated its ability to build muscle by 25% and reduce fat by 30%*. As veterans age, maintaining muscle mass, mobility, and balance becomes more challenging. The Emsculpt NEO can help with age-related muscle loss, improved balance, and mobility, promoting a healthier and more active lifestyle for aging veterans. The machine's versatility in treating different parts of the body, such as the abdomen, arms, legs, and buttocks, makes it suitable for veterans who may have difficulties building muscles in certain areas due to debilitating injuries, helping them maintain peak physical condition and performance.

"Providing Strength to Those That Serve" is at the heart of this collaboration. BTL Industries and JANZ Corporation are dedicated to supporting the health and well-being of those who serve the nation, offering them top-tier medical solutions.David Chmel, CEO of BTL Industries, stated, "We are thrilled to partner with JANZ Corporation to bring our advanced Emsculpt NEO technology to those who have dedicated their lives to serving our country. This partnership highlights our dedication to enhancing the health and well-being of military personnel and veterans, equipping them with the resources they need to stay in the best physical shape."

About BTL IndustriesFounded in 1993, BTL has grown to become one of the world's leading medical and aesthetic equipment manufacturers. With over 3,500 employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT NEO®, EMFACE®, EMSCULPT®, EMSELLA®, EMTONE®, EMFEMME 360™, EXION™, and Core to Floor®, as well as their proprietary HIFEM® and HIFES™. For additional information, please visitwww.bodybybtl.com.

April 11, 2024

BTL Industries, Inc., a leading provider of innovative medical aesthetic solutions, petitioned the U.S. Patent Office to cancel all 58 claims of U.S. Patent No. 8,961,511 owned by the company InMode Ltd.

"We have strong reasons to believe InMode's patent claims are invalid," explainedDavid Chmel, BTL's CEO, "and BTL has asked the United States Patent Office to initiate invalidation proceedings."

For more information about BTL and its medical solutions, please visitwww.bodybybtl.com.

ABOUT BTL
Founded in 1993, BTL has grown to become one of the world's leading medical and aesthetic equipment manufacturers. With over 3,500 employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT NEO^®, EMFACE^®, EMSCULPT^®, EMSELLA^®, EMTONE^®, EMFEMME 360™, EXION™, and Core to Floor^®, as well as their proprietary HIFEM^®and HIFES™. Please visitwww.bodybybtl.comfor additional information.

April 9, 2024

BTL Industries, a renowned leader in cutting-edge medical technologies, is excited to announce its participation in the upcoming American Society for Laser Medicine and Surgery (ASLMS) Conference, taking place fromApril 11 to April 14, 2024, inBaltimore, Maryland. This prestigious event brings together top experts, researchers, and practitioners in the field of medical laser applications and energy-based treatments.

BTL Industries is set to unveil its latest advancements in aesthetic and muscle enhancement at ASLMS, redefining possibilities for enhancing both form and function. With a commitment to innovation and excellence, BTL Industries continues to pave the way for transformative outcomes in medical technology, empowering healthcare professionals to deliver unparalleled solutions for diverse patient needs.

Highlighted below are the presentations featuring BTL Industries' groundbreaking products and technologies:

EMFACE

• Five oral presentations
• Topics include tackling challengingsubmentum cases with Emface, combination technique for Botulinum toxins and Emface treatments, histologic and clinical evaluation of Emface on submentum, facial rejuvenation and volumization with Emface, and facial lifting in Asian population
• E-Poster on the combination of injectables and Emface

EMSCULPT NEO

• Three oral presentations
• Topics include core strength in moms and seniors, muscle stimulation for functional enhancement, and obtaining an hourglass figurenoninvasively

EMSELLA

• Oral presentation
• Topics include enhancing the quality of life in elderly men withpost-prostatectomy incontinence.

Commenting on BTL Industries' leadership position in muscle stimulation technologies for enhancing both form and function,Rohit Mishra, Director of Product Management at BTL Industries, stated: "We are proud to lead the way in advancing the application of muscle stimulation techniques for optimizing both appearance and quality of life. Our commitment to research and development enables us to continuously push the boundaries of innovation, providing healthcare professionals with unparalleled tools to enhance patient outcomes and satisfaction."

BTL Industries looks forward to engaging with attendees, sharing insights, and fostering collaboration to drive further advancements in medical laser technology and energy-based therapies.

The American Society for Laser Medicine and Surgery Inc. (ASLMS) has the ultimate responsibility for the planning, development and content of continuing education programs and presentations, including those highlighted above. BTL did not direct content or influence the planning or implementation of the ASLMS 43^rdAnnual Conference. The spontaneous opinions expressed by speakers and participants during these activities belong to those individuals.

About BTL Industries:

Founded in 1993, BTL has grown to become one of the world's leading medical and aesthetic equipment manufacturers. With over 3,500 employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT NEO^®, EMFACE^®, EMSCULPT^®, EMSELLA^®, EMTONE^®, EMFEMME 360™, EXION™, and Core to Floor^®, as well as their proprietary HIFEM^®and HIFES™. Please visitwww.bodybybtl.comfor additional information.

January 18, 2024

In a grand celebration of its most successful year,BTL, a pioneer in the medical aesthetics industry, hosted its largest national sales meeting yet. This marked a significant milestone for the company, having reached a record revenue of680 million USDin 2023. The event was not just a commemoration of past achievements but also a stage for groundbreaking innovations. The spotlight was on the introduction of the new EMFACE Submentum applicator, a device poised to revolutionize the treatment of double chins.

BTL's technological prowess is long-established, and this addition to the EMFACE platform represents a new flagship in BTL's journey. Harnessing the power of patented Synchronized RF+ and HIFES™ technology for facial muscle stimulation, the EMFACE stands as the most innovative non-invasive procedure in the industry.

David Chmel, BTL's CEO, expressed his vision and confidence in the new product. "EMFACE is not just an innovation for today; it lays the foundation for future advancements. By focusing on new treatment areas, we ensure that our technological advancements continue to add value for our customers and redefine the industry."

Designed to prioritize patient comfort, the EMFACE Submentum applicator offers a needle-free and bruise-free treatment. Its noninvasive technology uniquely targets layers from skin to muscle, enhancing the aesthetic appearance with unprecedented precision and ease.

Jennifer Levine, MD, a renownedNew York City-based facial plastic surgeon, shared her enthusiasm for EMFACE's potential. "The EMFACE represents a revolution in double-chin treatments. We now have the ability to target the deeper structures non-invasively in a safe and effective manner."

For more information about the Emface applicator and other innovative products from BTL, please visit emface.com.

About BTL:
Founded in 1993, BTL has grown to become one of the world's leading medical and aesthetic equipment manufacturers. With over 3,000 employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT NEO^®, EMFACE^®, EMSCULPT^®, EMSELLA^®, EMTONE^®, EMFEMME 360™, EXION™, and Core to Floor^®, as well as their proprietary HIFEM^®and HIFES™. Please visitwww.bodybybtl.comfor additional information.